Tuesday, May 14, 2013

California a veritable hotbed of iPS cell patent activity, study finds

Frozen iPS cells courtesy of William Collins in the lab of Deepak Srivastava and Christopher Schlieve at the Gladstone Institutes.
It looks like California is a veritable hotbed of reprogrammed stem cell activity. (These are the iPS cells that are reprogrammed from adult tissues like skin.)

The publication Genetic Engineering News looked at new patents for iPS cell technology and found that world-wide, most of the activity was focused in California, Boston, Madison, Wisconsin, and Kyoto University.

They write:
California, the second most successful cluster, appears to reflect the “start up” cultures of the Bay Area and San Diego with strong academic support within the local universities. California is distinguished from Japan in that it also has a good number of smaller players in industry and multiple academic institutions trying to establish a foothold in the area.
One of CIRM's goals is to promote more biotech industry in the state working toward new stem cell-based therapies so it's nice to see that happening in the iPS cell field.

As the story says, we'll be posting the raw data used in this analysis on our website for others to peruse. We also have this list of our funding for iPS cell work.


No comments:

Post a Comment